Review: Albumin increases mortality in critically ill patients

Choi, Peter
September 2002
ACP Journal Club;Sep/Oct2002, Vol. 137 Issue 2, p51
Academic Journal
Discusses the effect of human albumin or plasma protein fraction on the mortality of critically ill patients with hypovolemia, burns or hypoalbuminemia. Information on data sources and study selection; Background on the debate about the safety of albumin; Analysis of the mortality rates associated with albumin versus control in critically ill patients.


Related Articles

  • Is There More Pro than Con in Probiotics in Critically Ill Adults? Kuritzky, Louis // Infectious Disease Alert;Jun2013, Vol. 32 Issue 9, p11 

    The article discusses a study on the benefits of probiotics ingestion in critically ill adults, by D. Barraud et al. and which was published in "Chest."

  • TTE with contrast yielded lower mortality than non-contrast TTE in critically ill patients. Ellis, Brian; Kalvaitis, Katie; Swain, Erik // Cardiology Today;Feb2014, Vol. 17 Issue 2, p38 

    The article discusses a study by M. Main et al and published in a 2014 issue of the "Journal of the American College of Cardiology," which found that transthoracic echocardiography (TTE) with contrast is associated with lower mortality that non-contrast TTE in critically ill patients.

  • Association Between Hyperglycemia and Increased Hospital Mortality in a Heterogeneous Population of Critically Ill Patients. Krinsley, James Stephen // Mayo Clinic Proceedings;Dec2003, Vol. 78 Issue 12, p1471 

    • Objective: To investigate the relationship between hyperglycemia and hospital mortality in a heterogeneous group of critically ill patients. • Patients and Methods: Retrospective data were reviewed for 1826 consecutive patients whose glucose values were obtained during their...

  • Increased Mortality Associated with Growth Hormone Treatment in Critically Ill Adults. Takala, Jukka; Ruokonen, Esko; Webster, Nigel R.; Nielsen, Michael S.; Zandstra, Durk F.; Vundelinckx, Guy; Hinds, Charles J. // New England Journal of Medicine;09/09/99, Vol. 341 Issue 11, p785 

    Background: The administration of growth hormone can attenuate the catabolic response to injury, surgery, and sepsis. However, the effect of high doses of growth hormone on the length of stay in intensive care and in the hospital, the duration of mechanical ventilation, and the outcome in...

  • Growth Hormone Therapy in Critically Ill Patients. Demling, Robert // New England Journal of Medicine;09/09/99, Vol. 341 Issue 11, p837 

    Editorial. Focuses on a study reported by Takala, et al in the September 9, 1999 issue of the `New England Journal of Medicine,' regarding an increase in mortality among critically ill patients treated with growth hormone. Discussion of results of previous studies; Possible negative effect of...

  • Glucose variability measures and their effect on mortality: a systematic review. Eslami, Saeid; Taherzadeh, Zhila; Schultz, Marcus J.; Abu-Hanna, Ameen // Intensive Care Medicine;Apr2011, Vol. 37 Issue 4, p583 

    Objective: To systematically review the medical literature on the association between glucose variability measures and mortality in critically ill patients. Methods: Studies assessing the association between a measure of glucose variability and mortality that reported original data from a...

  • Mortality in Perforated Peptic Ulcer Patients After Selective Management of Stratified Poor Risk Cases. Rahman, M. Mizanur; Islam, M. Saiful; Flora, Sabrina; Akhter, S. Fariduddin; Hossain, Shahid; Karim, Fazlul // World Journal of Surgery;Dec2007, Vol. 31 Issue 12, p2341 

    Perforated peptic ulcer disease continues to inflict high morbidity and mortality. Although patients can be stratified according to their surgical risk, optimal management has yet to be described. In this study we demonstrate a treatment option that improves the mortality among critically ill,...

  • Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Krinsley, James S.; Egi, Moritoki; Kiss, Alex; Devendra, Amin N.; Schuetz, Philipp; Maurer, Paula M.; Schultz, Marcus J.; van Hooijdonk, Roosmarijn T M; Kiyoshi, Morita; Mackenzie, Iain M. J.; Annane, Djillali; Stow, Peter; Nasraway, Stanley A.; Holewinski, Sharon; Holzinger, Ulrike; Preiser, Jean-Charles; Vincent, Jean-Louis; Bellomo, Rinaldo // Critical Care;2013, Vol. 17 Issue 2, Special section p1 

    Introduction: Hyperglycemia, hypoglycemia, and increased glycemic variability have each been independently associated with increased risk of mortality in critically ill patients. The role of diabetic status on modulating the relation of these three domains of glycemic control with mortality...

  • Association between haptoglobin, hemopexin and mortality in adults with sepsis. Janz, David R.; Bastarache, Julie A.; Sills, Gillian; Wickersham, Nancy; May, Addison K.; Bernard, Gordon R.; Ware, Lorraine B. // Critical Care;2013, Vol. 17 Issue 6, p1 

    Introduction Plasma levels of cell-free hemoglobin are associated with mortality in patients with sepsis; however descriptions of independent associations with free hemoglobin and free heme scavengers, haptoglobin and hemopexin, are lacking beyond their description as acute phase reactants. We...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics